HK Stock Market Move | Jiangsu Lopal Tech. Group (02465) rose by nearly 4%, the lithium iron phosphate industry is clearly heating up, and the company significantly narrowed losses in the third quarter.
Longevity Technology (02465) rose nearly 4%, as of the time of publication, it increased by 3.82% to HK$15.23, with a turnover of HK$220 million.
Jiangsu Lopal Tech. Group (02465) has risen nearly 4%, as of press time, it has risen by 3.82% to HK$15.23, with a turnover of HK$220 million.
On the news front, according to the Shanghai Securities News, with the stabilization of lithium prices hitting bottom, automobile manufacturers and battery producers are actively positioning themselves, and against the backdrop of the surge in global energy storage demand, the price of lithium iron phosphate, as the cost-effective choice for batteries, is quietly rebounding, rising by about 10% since October. Data from the Yangtze Nonferrous Metals website shows that since early October, most lithium battery material prices have risen significantly. As of November 13, the average price of lithium iron phosphate is about 36,900 yuan/ton, an increase of 3,300 yuan/ton since early October, with a increase of about 10%.
In addition, Jiangsu Lopal Tech. Group recently announced the holding of a conference on the performance of the third quarter. The announcement disclosed that the company will actively promote its layout in the new energy and new materials sectors, strengthen the development of lithium iron phosphate positive electrode materials business, including overseas production capacity layout, new product promotion, etc. At the same time, it will also increase its layout and promotion in the fields of new energy vehicles, energy storage, and data centers for its coolant product. In addition, the company has significantly reduced its losses in the third quarter and will actively improve the company's operating situation through the rigorous implementation of cost reduction and efficiency enhancement strategies, as well as measures to increase shipments of high-pressure density products.
Related Articles

Jiangsu Hengrui Pharmaceuticals (600276.SH): HRS-4642 Injection and other drugs have received clinical trial approval.

CMSC International: Raises target price of TENCENT (00700) to HKD 766, maintains "buy" rating.

Sichuan Teway Food Group's (603317.SH) application materials for the issuance of H shares have been accepted by the China Securities Regulatory Commission.
Jiangsu Hengrui Pharmaceuticals (600276.SH): HRS-4642 Injection and other drugs have received clinical trial approval.

CMSC International: Raises target price of TENCENT (00700) to HKD 766, maintains "buy" rating.

Sichuan Teway Food Group's (603317.SH) application materials for the issuance of H shares have been accepted by the China Securities Regulatory Commission.

RECOMMEND

Energy Storage Industry Set To Ride the AI Tailwind; UBS: Global Demand May Surge 40% Next Year
13/11/2025

Double Eleven’s Cooling To A Historic Low? A Necessary Step Toward E‑commerce Maturity
13/11/2025

On The Eve of L3 Mass Commercialization: How Autonomous Driving Will Reconfigure a Trillion‑Yuan Service Market
13/11/2025


